Velocity Clinical Research

Meridian, Idaho 83642

1 studies enrolling now · 15 studies all time

What they study most

COVID-19, Covid19, Cytomegalovirus Infection, Dyslipidemias, Early Alzheimer's Disease, Early Alzheimer´s Disease, Epstein-Barr Virus Infection, Generalized Anxiety Disorder, Gout, Gout Flare, High Cholesterol, Hypercholesterolemia

Studies at this site

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool — Recruiting now
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder — Running, not enrolling
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults — Running, not enrolling
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 — Completed
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
A Multi-Center Prospective Open Label Study of a Web-based Application for Pulse Rate in Adult Patients — Completed
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients — Completed
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines — Completed
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers — Completed
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines — Completed
Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD — Completed
Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy — Completed
Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults — Completed